GILD
Gilead Sciences Inc
Price:  
92.38 
USD
Volume:  
7,246,563.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Gilead WACC - Weighted Average Cost of Capital

The WACC of Gilead Sciences Inc (GILD) is 7.9%.

The Cost of Equity of Gilead Sciences Inc (GILD) is 8.90%.
The Cost of Debt of Gilead Sciences Inc (GILD) is 4.25%.

Range Selected
Cost of equity 7.60% - 10.20% 8.90%
Tax rate 20.20% - 22.90% 21.55%
Cost of debt 4.00% - 4.50% 4.25%
WACC 6.8% - 9.0% 7.9%
WACC

Gilead WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.8 0.95
Additional risk adjustments 0.0% 0.5%
Cost of equity 7.60% 10.20%
Tax rate 20.20% 22.90%
Debt/Equity ratio 0.22 0.22
Cost of debt 4.00% 4.50%
After-tax WACC 6.8% 9.0%
Selected WACC 7.9%